大會議程

 

09:00-09:30

Registration

 

Opening Remarks

09:20-09:30

Dr. Yun Yen
President, Taipei Medical University

09:30-09:40

Dr. Gi-Shih Lien
Superintendent, Taipei Medical University-Wan Fang Hospital
 


Introduction of keynote speakers

09:50-10:00

Dr. Li-Tzong Chen
Director, National Institute of Cancer Research, National Health Research Institutes
 

  Keynote speeches

10:00-11:00

Promise of Metronomic Chemotherapy Revealed in Preclinical Models of Advanced Metastatic Disease

 

Dr. Robert S. Kerbel
Professor of Laboratory Medicine and Pathobiology, University of Toronto
Senior Scientist, Molecular and Cellular Biology Research, Sunnybrook Health Sciences Centre, Canada


11:00-12:00

Selecting the Most Appropriate Chemotherapy Partner and Dosage for Checkpoint Inhibitors

 

Dr. Francesco Bertolini
Director, Laboratory Division of Hematology/Oncology, European Institute of Oncology, Milan, Italy
 

 

 

12:00-13:00

Lunch Break

 

Session Chairman

Dr. Robert S. Kerbel

13:00-14:00

The Double Edged Sword of Cancer Therapy

 

Dr. Yuval Shaked
Associate Professor, Vice Dean of Research, Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
 

14:00-15:00

Metronomics-fulfilling Unmet Needs Beyond Level A Evidence

 

Dr. Nicolas Andre
Service d’Hématologie et Oncologie Pédiatrique, Centre Hospitalier-Universitaire Timone Enfants, AP-HM, and Metronomics Global Health Initiative, Marseille, France
 

 

 

15:00-15:20

Coffee Break

 

 

Session Chairman

Dr. Gi-Ming Lai
Vice Superintendent, Taipei Medical University-Wan Fang Hospital
 

15:20-16:00

Clinical Studies of Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma ~ the Past and the Future

 

Dr. Chih-Hung Hsu
Professor, Department of Oncology, National Taiwan University Hospital
 

16:00-16:50

Metronomic Chemotherapy Tempers the Stromal Response to Enhance Anti-tumor Efficacy

 

Dr. Kelvin K. Tsai
Associate Professor, Graduate Institute of Clinical Medicine, College of Medicine, TMU; Joint Associate Investigator, National Institute of Cancer Research, National Health Research Institutes
 

 


16:50-17:00

Closing Remarks

 

Dr. Chao-Ching Huang
Dean, College of Medicine, Taipei Medical University